v3.26.3
Summary of significant accounting policies (Tables)
 9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of financial assets and liabilities
                
   Total   Level 1   Level 2   Level 3 
Short term investments – assets:                    
Common stock  $48,965,766   $48,965,766   $–   $– 
Pre-funded warrants   3,686,000    –    3,686,000    – 
Non-public warrants   740,000    –    –    740,000 
Total short-term investments – assets  $53,391,766   $48,965,766   $3,686,000   $740,000 
                     
Contingent consideration from Rotor Lab acquisition  $3,000,000   $3,000,000   $–   $– 
Schedule of assumptions used
    
Supplemental Information  Non-public Warrants 
Expected term of the warrants (years)   1.00 
Stock price  $4.56 
Warrant exercise price  $6.00 
Risk free interest rate   4.54% 
Volatility   102.76% 
Schedule of level 3 financial instruments
                       
    December 31,    

Purchases,

Issuances and

     Change in     September 30,  
    2025     Settlements     Fair Value     2026  
Non-public warrants investment   $ 1,135,000     $ –     $ (395,000 )   $ 740,000  
Schedule of short-term investments
            
Short-term investments at fair value  Cost   Cumulative Unrealized Gains (Losses)   Fair Value 
Common stock  $60,649,998   $(11,684,231)  $48,965,766 
Pre-funded warrants   2,850,000    836,000    3,686,000 
Non-public warrants   195,000    545,000    740,000 
Total  $63,694,998   $(10,303,231)  $53,391,766 

  

            
Short-term investments at cost  Cost  

Impairment / Other

Adjustments

   Adjusted Cost 
Common stock  $10,000,000   $–   $10,000,000 
Preferred stock   5,000,000    –    5,000,000 
Pre-funded warrants   30,000,000    –    30,000,000 
Total  $45,000,000   $–   $45,000,000 
Schedule of disaggregated by revenue
          
   For the Three months Ended
September 30		 
   2026   2025 
Retail revenue  $1,346,107   $1,158,449 
Enterprise revenue   12,556,925    976,139 
Total revenue  $13,903,032   $2,134,588 

 

The following table presents the Company’s revenue disaggregated by revenue type for the period ended:

 

   For the Nine months Ended 
   September 30 
   2026   2025 
Retail revenue  $4,521,031   $5,012,473 
Enterprise revenue   34,200,305    1,288,384 
Total revenue  $38,721,336   $6,300,857 
Schedule of cumulative translation adjustments
    
Balance as of December 31, 2025  $3,470 
Foreign currency translation adjustment related to Rotor Lab   20,878 
Balance as of September 30, 2026  $24,348 
Schedule of income per share
                       
    For the Three months Ended     For the Nine months Ended  
    September 30     September 30  
    2026     2025     2026     2025  
Weighted average shares used in computing net income per share of common stock, basic     49,968,207       30,002,179       46,094,557       22,610,516  
Add incremental shares:                                
Stock based awards (options and restricted stock units)     –       257,303       –       –  
Warrants     –       321,712       –       –  
Weighted average shares used in computing net income per share of common stock, diluted     49,968,207       30,581,194       46,094,557       22,610,516  
Schedule of anti dilutive shares
        
   For the Nine months Ended   For the Nine months Ended 
   September 30   September 30 
   2026   2025 
Unvested stock options   3,412,793    682,600 
Unvested restricted stock awards   726,667    550,000 
Warrants   –    1,154,473 
Total   4,139,460    2,387,073